<DOC>
	<DOCNO>NCT01807169</DOCNO>
	<brief_summary>The endoscopic management patient anti platelet agent ( APA ) wide problem , prevalence patient type therapy steadily increase . The benefit / risk balance stop continue APA digestive endoscopic procedure confronts u every day clinical practice another : relationship thrombosis / hemorrhage . Molecules commonly use today aspirin clopidogrel . Current recommendation European Society Gastrointestinal Endoscopy ( ESGE ) allow maintenance aspirin polypectomy . Some preliminary data show risk bleed endoscopic mucosal resection ( EMR ) aspirin significantly high polypectomy . The concept polypectomy / EMR without stop aspirin progressively accept return gradually usual practice . However , procedure still allow clopidogrel , dual APA therapy , absence relevant data subject literature . It necessary achieve large national multicenter study , clarify risk post recto colonic EMR polypectomy bleed patient clopidogrel alone combination ( aspirin clopidogrel ) take account endoscopic preventive measure use daily practice endoscopists expert center ( clip , ligature loop device , preventive adrenalin injection ) . The aim `` MEDOC '' study determine incidence immediate delay bleeding colonic polypectomy / EMR patient clopidogrel . It expect work incidence post-polypectomy bleeding close observed implementation action population without anti platelet agent .</brief_summary>
	<brief_title>Recto Colonic Endoscopic Mucosal Resection Polypectomy Under Clopidogrel</brief_title>
	<detailed_description>The endoscopic management patient anti platelet agent ( APA ) wide problem , due dramatically increase prevalence patient therapy . The benefit / risk balance stop continue APA digestive endoscopic procedure confronts u every day clinical practice another : relationship thrombosis / hemorrhage . The maintenance APA particularly essential acute coronary episode , long term , prevention recurrent thrombotic cardiovascular disease . Molecules commonly use today aspirin clopidogrel . Current recommendation European Society Gastrointestinal Endoscopy ( ESGE ) allow maintenance aspirin polypectomy . Some preliminary data show risk bleed endoscopic mucosal resection ( EMR ) aspirin significantly high polypectomy . The concept polypectomy / EMR without stop aspirin progressively accept return gradually usual practice . However , procedure still allow clopidogrel , dual APA therapy , absence relevant data subject literature . However recent study disrupt problem different reason : ) endoscopic haemostatic preventive measure demonstrate efficacy reduce rate immediate delay bleed post polypectomy EMR ; ii ) inadequate modification untimely stop APA treatment always complicate severe vascular thrombosis event 5 % patient ; iii ) three retrospective study relativize risk bleed colonic polypectomy clopidogrel . It therefore essential carry prospective , large-scale , multicenter , study clarify risk post colonic EMR/polypectomy bleeding patient clopidogrel alone combination ( aspirin clopidogrel ) take account endoscopic preventive measure use daily practice endoscopists expert center ( clip , ligature loop device , preventive adrenalin injection ) . The aim `` MEDOC '' study determine incidence immediate delay bleeding colonic polypectomy / EMR patient clopidogrel . The study present interventional prospective multicentric national design . 300 patient include . The duration study inclusion 18 month . It expect work incidence post-polypectomy bleeding close observed implementation action population without anti platelet agent .</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Age â‰¥ 18 year , male female Polypectomy AND / OR mucosectomy ( EMR ) perform clopidogrel and/or aspirin colonoscopy inability defer action Taking single daily dose clopidogrel longterm ( 3 month ) treatment clopidogrel aspirin ( aspirin &lt; 375 mg 3 month ) prevention cardiovascular thromboembolic risk major medium secondary prevention Affiliation regime national health protection Informed consent patient 's write obtain No participation another clinical study Contraindications achievement lower gastrointestinal endoscopy Taking single daily dose clopidogrel antiplatelet , anti vitamin K ( AVK ) , heparin anti bi aggregation context cardiovascular prevention Taking chronic anti inflammatory drug ( least weekly ) Resection technique submucosal dissection Haemorrhagic disease , disorder hemostasis coagulation ( PT &lt; 60 % , aPTT &gt; 40 sec . And platelet &lt; 100000/mm3 ) , hematologic malignancy , chronic liver cirrhosis classify Child Pugh B C , acute chronic renal failure Acute Coronary Syndrome &lt; 3 month receive percutaneous coronary intervention ( PCI ) . Angioplasty placement stent drug evaluation ( context acute coronary syndrome ) &lt; 3 month . Angioplasty placement bare metal stent ( context acute coronary syndrome ) &lt; 4 week . Pregnant woman , nurse Not sign write consent / mental disability subject make participation trial impossible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>colon</keyword>
	<keyword>endoscopy</keyword>
	<keyword>resection</keyword>
	<keyword>clopidogrel</keyword>
</DOC>